Alejandro Aran is an experienced professional in the fields of regenerative medicine and preclinical research. As Facility Manager at Kadimastem Ltd. since October 2013, Alejandro oversees operations at a leading company focused on stem cell-based therapeutics for diabetes and neurodegenerative disorders. In addition, Alejandro serves as Study Director for Preclinical Pharmacology and Efficacy Studies at Pharmaseed Ltd., which specializes in translational research and GLP-accredited laboratory services. With a robust background including research roles at ILSI and D-Pharm, and academic credentials such as a Master in Animal Sciences from The Hebrew University of Jerusalem, Alejandro has also fulfilled technical training in HVAC systems and workplace safety.
Previous companies